Susquehanna International Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.83M Sell
885,526
-175,942
-17% -$987K ﹤0.01% 4299
2025
Q4
$7.43M Sell
1,061,468
-449,643
-30% -$3.52M ﹤0.01% 3451
2025
Q3
$11.7M Sell
1,511,111
-535,162
-26% -$4.18M ﹤0.01% 2851
2025
Q2
$17.8M Buy
2,046,273
+1,292,854
+172% +$9.37M ﹤0.01% 2125
2025
Q1
$6M Sell
753,419
-188,944
-20% -$1.91M ﹤0.01% 3313
2024
Q4
$8.57M Buy
942,363
+571,552
+154% +$5.52M ﹤0.01% 2848
2024
Q3
$3.4M Sell
370,811
-1,731,303
-82% -$14.3M ﹤0.01% 4320
2024
Q2
$20.6M Buy
2,102,114
+1,389,716
+195% +$17M ﹤0.01% 1695
2024
Q1
$10.8M Sell
712,398
-985,065
-58% -$17.9M ﹤0.01% 2509
2023
Q4
$36.6M Buy
1,697,463
+859,001
+102% +$15.8M 0.01% 1267
2023
Q3
$15.6M Buy
838,462
+233,683
+39% +$5.45M ﹤0.01% 2036
2023
Q2
$15.3M Buy
604,779
+189,727
+46% +$4.78M ﹤0.01% 2001
2023
Q1
$10.7M Buy
415,052
+63,095
+18% +$1.69M ﹤0.01% 2347
2022
Q4
$8.32M Buy
351,957
+279,728
+387% +$7.54M ﹤0.01% 2505
2022
Q3
$1.83M Sell
72,229
-618,768
-90% -$21.7M ﹤0.01% 5095
2022
Q2
$22.9M Buy
690,997
+206,828
+43% +$8.78M 0.01% 1342
2022
Q1
$34.9M Sell
484,169
-214,102
-31% -$15.4M 0.01% 1231
2021
Q4
$64.1M Sell
698,271
-229,598
-25% -$27.4M 0.01% 950
2021
Q3
$118M Sell
927,869
-150,542
-14% -$21.9M 0.02% 712
2021
Q2
$179M Sell
1,078,411
-246,070
-19% -$39.9M 0.03% 544
2021
Q1
$241M Buy
1,324,481
+501,847
+61% +$116M 0.04% 387
2020
Q4
$164M Buy
822,634
+290,329
+55% +$59M 0.03% 479
2020
Q3
$117M Buy
532,305
+91,928
+21% +$19.5M 0.02% 515
2020
Q2
$84M Buy
440,377
+117,175
+36% +$20.5M 0.02% 575
2020
Q1
$50.1M Buy
323,202
+184,769
+133% +$21.5M 0.02% 655
2019
Q4
$11.6M Buy
138,433
+104,866
+312% +$7.98M ﹤0.01% 1928
2019
Q3
$2.27M Buy
33,567
+1,580
+5% +$104K ﹤0.01% 3946
2019
Q2
$2.12M Sell
31,987
-120,268
-79% -$7.01M ﹤0.01% 4060
2019
Q1
$8.46M Sell
152,255
-46,456
-23% -$2.84M ﹤0.01% 1899
2018
Q4
$9.85M Sell
198,711
-42,399
-18% -$2.59M ﹤0.01% 1616
2018
Q3
$20.8M Buy
241,110
+158,537
+192% +$11.3M 0.01% 1302
2018
Q2
$4.79M Sell
82,573
-32,865
-28% -$1.61M ﹤0.01% 2761
2018
Q1
$4.65M Buy
115,438
+101,367
+720% +$3.83M ﹤0.01% 2628
2017
Q4
$490K Buy
+14,071
New +$467K ﹤0.01% 6672
2017
Q2
Sell
-25,522
Closed -$744K 9827
2017
Q1
$638K Buy
+25,522
New +$531K ﹤0.01% 6037
2016
Q4
Sell
-18,578
Closed -$316K 10146
2016
Q3
$340K Buy
+18,578
New +$326K ﹤0.01% 6727

Other funds holding TDOC

Susquehanna International Group's TDOC Position: Q1 2026 in Review

Susquehanna International Group reduced its Teladoc Health (TDOC) stake by 17% in Q1 2026, selling an estimated $987K and leaving 885,526 shares worth $4.83M. The position accounts for ﹤0.01% of the portfolio, ranked #4299.

Susquehanna International Group first reported a position in TDOC in Q3 2016 and has held it in 36 quarters since. The position peaked at $241M in Q1 2021. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Susquehanna International Group held 885,526 shares of Teladoc Health worth $4.83M as of Q1 2026.
  • Susquehanna International Group sold 175,942 Teladoc Health shares in Q1 2026, an estimated $987K.
  • Teladoc Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4299 holding.
  • Susquehanna International Group first reported a position in Teladoc Health in Q3 2016 and has held it in 36 quarters since.
  • Susquehanna International Group's Teladoc Health position peaked at $241M in Q1 2021.
  • 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.